{"id":"placebo-of-ofloxacine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL3770173","moleculeType":"Small molecule","molecularWeight":"440.32"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, ofloxacine's mechanism of action is essentially inert, with no known biological activity. It is used as a control in clinical trials to compare the efficacy of active treatments.","oneSentence":"This drug is a placebo, meaning it has no active pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:19.072Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial conjunctivitis"}]},"trialDetails":[{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT07320534","phase":"PHASE4","title":"Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase","status":"NOT_YET_RECRUITING","sponsor":"Gadjah Mada University","startDate":"2026-01-01","conditions":"Neutropenic Fever, Acute Lymphoblastic Leukemia","enrollment":124},{"nctId":"NCT04951986","phase":"PHASE3","title":"Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-08-11","conditions":"Disseminated Tuberculosis, HIV","enrollment":732},{"nctId":"NCT07240077","phase":"PHASE4","title":"Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-01-01","conditions":"Bacteremia, Streptococcus Infection","enrollment":165},{"nctId":"NCT06859450","phase":"PHASE2, PHASE3","title":"Local Antibiotic Delivery for Community Acquired Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2025-03-04","conditions":"Community Acquired Pneumonia (CAP)","enrollment":36},{"nctId":"NCT00677365","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-06","conditions":"Cystic Fibrosis (CF)","enrollment":151},{"nctId":"NCT00739648","phase":"PHASE2","title":"A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-10","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":322},{"nctId":"NCT01180634","phase":"PHASE3","title":"MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-11-04","conditions":"Cystic Fibrosis","enrollment":330},{"nctId":"NCT00752414","phase":"PHASE1","title":"A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-07","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":21},{"nctId":"NCT00503490","phase":"PHASE1","title":"Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Amgen","startDate":"2007-06","conditions":"Cystic Fibrosis","enrollment":40},{"nctId":"NCT05799326","phase":"NA","title":"Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Yi Yang","startDate":"2023-06-30","conditions":"Acute Ischemic Stroke","enrollment":100},{"nctId":"NCT05741905","phase":"NA","title":"Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Yi Yang","startDate":"2023-06-01","conditions":"Acute Ischemic Stroke","enrollment":100},{"nctId":"NCT02424461","phase":"PHASE3","title":"Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-01-25","conditions":"Acute Male Urinary Tract Infection","enrollment":274},{"nctId":"NCT02981615","phase":"PHASE3","title":"Phase 3 Multicenter Randomized Double Blind Placebo Controlled Study With Antibacterial Prophylaxis in Azacitidine Treated MDS Patients","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2017-08-01","conditions":"Prevention","enrollment":67},{"nctId":"NCT03551210","phase":"PHASE3","title":"Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"R-Pharm","startDate":"2016-05-04","conditions":"Pneumonia, Bacterial","enrollment":342},{"nctId":"NCT05728424","phase":"PHASE3","title":"One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2022-09-20","conditions":"Helicobacter Pylori Infection","enrollment":246},{"nctId":"NCT05575427","phase":"PHASE4","title":"Efficacy of Combination Therapy With Minocycline for Treatment of Stenotrophomonas Maltophilia Infections","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2022-11-24","conditions":"Hospital Infections","enrollment":112},{"nctId":"NCT03032510","phase":"PHASE3","title":"Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2017-01","conditions":"Complicated Urinary Tract Infections","enrollment":1205},{"nctId":"NCT03698682","phase":"PHASE2","title":"Short Compared With Standard Duration of Antibiotic Treatment for AECOPD","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2018-01-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":310},{"nctId":"NCT01988779","phase":"PHASE3","title":"Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2013-10","conditions":"Chronic Rhinosinusitis","enrollment":33},{"nctId":"NCT03257423","phase":"NA","title":"Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2017-04-04","conditions":"Acute Appendicitis","enrollment":200},{"nctId":"NCT03234296","phase":"NA","title":"Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis","status":"ENROLLING_BY_INVITATION","sponsor":"Turku University Hospital","startDate":"2017-08-09","conditions":"Acute Appendicitis","enrollment":147},{"nctId":"NCT02067780","phase":"PHASE3","title":"Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2017-05-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":310},{"nctId":"NCT00563433","phase":"PHASE3","title":"MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers","status":"COMPLETED","sponsor":"Abeona Therapeutics, Inc","startDate":"1994-08","conditions":"Diabetic Foot Ulcers","enrollment":342},{"nctId":"NCT00563394","phase":"PHASE3","title":"MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers","status":"COMPLETED","sponsor":"Abeona Therapeutics, Inc","startDate":"1994-08","conditions":"Diabetic Foot Ulcers","enrollment":584},{"nctId":"NCT02024555","phase":"PHASE2","title":"Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2014-03","conditions":"Sarcoidosis; Antimycobacterial Therapy","enrollment":97},{"nctId":"NCT04352062","phase":"NA","title":"Melatonin Supplementation in Postmenopausal Women With H. Pylori-associated Dyspepsia","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2011-01-09","conditions":"Melatonin Deficiency","enrollment":152},{"nctId":"NCT01500382","phase":"PHASE1","title":"A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-02-27","conditions":"Overactive Bladder, Overactive Urinary Bladder","enrollment":4},{"nctId":"NCT03395249","phase":"PHASE1","title":"Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2017-10-20","conditions":"Healthy Volunteers","enrollment":124},{"nctId":"NCT02486627","phase":"PHASE3","title":"A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Achaogen, Inc.","startDate":"2016-01-11","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":609},{"nctId":"NCT01096849","phase":"PHASE2","title":"A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Achaogen, Inc.","startDate":"2010-07-13","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":145},{"nctId":"NCT03472144","phase":"PHASE3","title":"Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis","status":"UNKNOWN","sponsor":"LifeBridge Health","startDate":"2017-07-07","conditions":"Chronic Sinusitis, Ethmoidal, Chronic Sinusitis - Ethmoidal Anterior, Chronic Sinusitis","enrollment":60},{"nctId":"NCT03160807","phase":"PHASE4","title":"Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections","status":"UNKNOWN","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-04-15","conditions":"Urinary Tract Infection","enrollment":214},{"nctId":"NCT01034176","phase":"PHASE4","title":"BK Treatment Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2009-02","conditions":"BK Viremia","enrollment":43},{"nctId":"NCT03106103","phase":"","title":"Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2009-02","conditions":"Female Stress Incontinence","enrollment":217},{"nctId":"NCT00362869","phase":"PHASE1","title":"Enteroaggregative E.Coli (EAEC)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-02","conditions":"Escherichia Coli Infections","enrollment":5},{"nctId":"NCT01074554","phase":"PHASE1, PHASE2","title":"Trial of Antimycobacterial Therapy in Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-02","conditions":"Sarcoidosis","enrollment":30},{"nctId":"NCT01618591","phase":"NA","title":"Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea","status":"TERMINATED","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2012-09","conditions":"Acute Watery Diarrhea, Dysentery/Febrile Diarrhea","enrollment":384},{"nctId":"NCT00789997","phase":"PHASE2, PHASE3","title":"TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2008-11","conditions":"COPD Exacerbation","enrollment":81},{"nctId":"NCT02439632","phase":"PHASE3","title":"A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2014-02","conditions":"Acute Lower Urinary Tract Infection","enrollment":216},{"nctId":"NCT02157571","phase":"PHASE3","title":"A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Exacerbations of Chronic Bronchitis With Levofloxacin Hydrochloride Tablet as Active Control","status":"UNKNOWN","sponsor":"Lee's Pharmaceutical Limited","startDate":"2013-06","conditions":"Acute Exacerbations of Chronic Bronchitis","enrollment":360},{"nctId":"NCT02094703","phase":"PHASE4","title":"The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females","status":"UNKNOWN","sponsor":"Dr Cipto Mangunkusumo General Hospital","startDate":"2013-04","conditions":"Urinary Tract Infection","enrollment":126},{"nctId":"NCT00402688","phase":"PHASE3","title":"An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-11","conditions":"Prostatitis","enrollment":242},{"nctId":"NCT00005590","phase":"PHASE3","title":"Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma","status":"COMPLETED","sponsor":"Cancer Research Campaign Clinical Trials Centre","startDate":"1999-08","conditions":"Brain and Central Nervous System Tumors, Breast Cancer, Extragonadal Germ Cell Tumor","enrollment":""},{"nctId":"NCT01745328","phase":"NA","title":"Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine","status":"UNKNOWN","sponsor":"Beijing Institute of Disease Control and Prevention","startDate":"2009-01","conditions":"Recurrent Urinary Tract Infection","enrollment":150},{"nctId":"NCT00644449","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Bronchitis, Chronic","enrollment":551},{"nctId":"NCT00643409","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Maxillary Sinusitis","enrollment":541},{"nctId":"NCT00643734","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-04","conditions":"Pneumonia","enrollment":468},{"nctId":"NCT00621387","phase":"NA","title":"Study of Long-Term Antibiotic Treatment in Reactive Arthritis","status":"COMPLETED","sponsor":"University of Helsinki","startDate":"1993-11","conditions":"Reactive Arthritis","enrollment":56},{"nctId":"NCT00215007","phase":"PHASE2, PHASE3","title":"Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"","conditions":"Malignancy, Allogeneic Stem Cell Transplantation","enrollment":""},{"nctId":"NCT00513396","phase":"PHASE2, PHASE3","title":"High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis","status":"COMPLETED","sponsor":"GSVM Medical College","startDate":"2004-01","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":134}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of ofloxacine","genericName":"Placebo of ofloxacine","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a placebo, meaning it has no active pharmacological effect. Used for Bacterial conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}